Panax ginseng C.A.Meyer
Species
KNApSAcK Entry
| Organism name | Panax ginseng C.A.Meyer |
|---|---|
| Genus | Panax |
| Family | Araliaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Panax |
|---|---|
| Linked NCBI taxonomy ID | 4053 |
| Linked level | genus |
Family
| Family in NCBI taxonomy | Araliaceae |
|---|---|
| ID | 4050 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Metabolite list (37)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00029947
|
Ginsenoside Ro
/ Polysciasaponin P3 / Chikusetsusaponin 5 / Chikusetsusaponin V |
CHEMBL488317
|
C064378
|
No. 9 | No. 51 |
|
||
|
C00030393
|
Ginsenoside Ra3
|
No. 11 | No. 51 |
|
||||
|
C00033882
|
Ginsenoside Rs1
|
No. 11 | No. 51 |
|
||||
|
C00003535
|
Ginsenoside R1
/ Notoginsenoside R1 |
CHEMBL507115
|
C072936
|
No. 11 | No. 51 |
|
||
|
C00030260
|
Floralginsenoside M
/ (-)-Floralginsenoside M |
No. 11 | No. 51 |
|
||||
|
C00030261
|
Floralginsenoside N
/ (+)-Floralginsenoside N |
No. 11 | No. 51 |
|
||||
|
C00030262
|
Floralginsenoside O
/ (+)-Floralginsenoside O |
No. 11 | No. 51 |
|
||||
|
C00030263
|
Floralginsenoside P
/ (+)-Floralginsenoside P |
No. 11 | No. 51 |
|
||||
|
C00033883
|
Ginsenoside Rs2
|
No. 11 | No. 51 |
|
||||
|
C00030394
|
Ginsenoside Rb1
/ Sanchinoside E1 / Sanchinoside Rb1 |
CHEMBL501515
|
2 / 0 / 0 | No. 11 | No. 51 |
|
||
|
C00030395
|
Ginsenoside Rb2
|
CHEMBL449303
CHEMBL507688 CHEMBL452438 |
C048026
|
2 / 0 / 0 | No. 11 | No. 51 |
|
|
|
C00030396
|
Gypenoside IV
/ Ginsenoside Rb3 |
CHEMBL449303
CHEMBL507688 CHEMBL452438 |
C044463
|
2 / 0 / 0 | No. 11 | No. 51 |
|
|
|
C00030397
|
Ginsenoside Rc
|
CHEMBL451702
|
C044462
|
No. 11 | No. 51 |
|
||
|
C00030398
|
Ginsenoside Rd
|
CHEMBL473659
|
C049863
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
|
|
C00033874
|
Ginsenoside Ra2
|
No. 11 | No. 51 |
|
||||
|
C00031120
|
Quinquenoside R1
|
No. 11 | No. 51 |
|
||||
|
C00033873
|
Ginsenoside Ra1
|
No. 11 | No. 51 |
|
||||
|
C00030856
|
Ginsenoside R2
/ Notoginsenoside R2 |
No. 32 | No. 51 |
|
||||
|
C00033886
|
Ginsenoside Rs5
/ (+)-Ginsenoside Rs5 |
No. 32 | No. 51 |
|
||||
|
C00030400
|
Ginsenoside Rg3
|
CHEMBL398412
CHEMBL1095008 CHEMBL1735785 CHEMBL2151041 |
C097367
|
2 / 0 / 0 | 5 / 2 | No. 32 | No. 51 |
|
|
C00033875
|
Ginsenoside Rg5
|
CHEMBL400244
|
No. 32 | No. 51 |
|
|||
|
C00033876
|
Ginsenoside Rg6
|
No. 32 | No. 51 |
|
||||
|
C00033885
|
Ginsenoside Rs4
/ (+)-Ginsenoside Rs4 |
No. 32 | No. 51 |
|
||||
|
C00033884
|
Ginsenoside Rs3
/ (+)-Ginsenoside Rs3 |
No. 32 | No. 51 |
|
||||
|
C00033879
|
Ginsenoside Rk1
/ (+)-Ginsenoside Rk1 |
CHEMBL251235
|
No. 32 | No. 51 |
|
|||
|
C00029310
|
Ginsenoside F4
/ (20E)-Ginsenoside F4 / (-)-(20E)-Ginsenoside F4 |
No. 32 | No. 51 |
|
||||
|
C00033880
|
Ginsenoside Rk2
/ (+)-Ginsenoside Rk2 |
No. 99 |
|
|||||
|
C00033888
|
Ginsenoside Rs7
/ (+)-Ginsenoside Rs7 |
No. 99 |
|
|||||
|
C00033881
|
Ginsenoside Rk3
|
No. 99 |
|
|||||
|
C00033878
|
Ginsenoside Rh4
/ (+)-Ginsenoside Rh4 |
CHEMBL504029
|
No. 99 |
|
||||
|
C00033877
|
Ginsenoside Rh3
|
C055306
|
No. 99 |
|
||||
|
C00030402
|
Ginsenoside Rh1
|
CHEMBL466844
|
C425564
|
8 / 0 | No. 99 |
|
||
|
C00033887
|
Ginsenoside Rs6
/ (+)-Ginsenoside Rs6 |
No. 99 |
|
|||||
|
C00029440
|
Ginsenoside Rh2
/ 20(R)-Ginsenoside Rh2 |
CHEMBL1783834
CHEMBL1783835 CHEMBL1981496 |
No. 99 |
|
||||
|
C00035627
|
Ginsinsene
|
No. 1819 |
|
|||||
|
C00035723
|
Panaginsene
|
No. 1819 |
|
|||||
|
C00035724
|
Panaxene
|
No. 3304 |
|
Human Protein / Gene in interactions
2 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P11387 | DNA topoisomerase 1 | Isomerase | C00030394 C00030395 C00030396 C00030398 C00030400 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00030394 C00030395 C00030396 C00030398 C00030400 | 0 / 0 |
13 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00030400
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00030400
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00030400
|
| 354 | KLK3, APS, KLK2A1, PSA, hK3 | kallikrein-related peptidase 3 (EC:3.4.21.77) |
C00030400
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00030400
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00030402
|
| 3676 | ITGA4, CD49D, IA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
C00030402
|
| 3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00030402
|
| 3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00030402
|
| 3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00030402
|
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00030402
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00030402
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00030402
|